Recent In Life Sciences

Cancer is abnormal,uncontrollable growth  of cells.Many people spend their whole lives to find some solution for cancer. Some of them just wasted their lives, but some of them are almost at the end. Rudolf Brojs is the person who made a special drink which is extremely effective in the treatment of cancer. His amazing beverage has cured over 4 5 000 people who has suffered from cancer. According to his opinion, the consumption of protein can treat this disease. The treatment of this person lasts for 45 days. Rudolf recommends only consuming his juice and tea. You will improve your overall health, starve and kill the cancer cells during these 42 day. How to prepare juice? In gredients : Radishes-2% Potatoes-3% Celery Root-20% Carrots-20% Beetroot-55% You only have to place all the ingredients in a blender (juicer) and mix well. Do not forget that you should consume this juice as your body requires, do not overdo with the consumption of the beverage. How it works?Beets are

A research team, led by Dr. Robert Nagele from Rowan University School of Osteopathic Medicine and Durin Technologies, Inc., has announced the development of a blood test that leverages the body’s immune response system to detect an early stage of Alzheimer’s disease – referred to as the mild cognitive impairment (MCI) stage – with unparalleled accuracy. In a “proof of concept” study involving 236 subjects, the test demonstrated an overall accuracy, sensitivity and specificity rate of 100 percent in identifying subjects whose MCI was actually caused by an early stage of Alzheimer’s disease. “About 60 percent of all MCI patients have MCI caused by an early stage of Alzheimer’s disease. The remaining 40 percent of cases are caused by other factors, including vascular issues, drug side-effects and depression. To provide proper care, physicians need to know which cases of MCI are due to early Alzheimer’s and which are not,” said Cassandra DeMarshall, the study’s lead author, and a PhD can

The new device has been developed by the Dutch company Philips the instrument is called the M inicare I -2 0 . A new, portable device can assess patients for the risk of developing a heart attack by screening a single drop of blood. The test is also five times faster than comparable diagnostic devices. The device works by assessing levels of cardiac troponin I (cTnI). This is a protein released by heart muscle into the blood following a heart attack. Detection of this specific protein informs the healthcare professional of the patient risk and allows appropriate treatment to be administered. Troponin is a complex of three regulatory proteins (troponin C, troponin I, and troponin T), and they are necessary for muscle contraction in both skeletal muscle and cardiac muscle. Subtypes of troponin (cardiac I) are specific indicators of damage to the heart muscle (myocardium). Assessing the levels of troponin I in the blood is important to distinguish between patients who complain of che

Bioengineers at the University of California, San Diego have developed an electrical graphene chip capable of detecting mutations in DNA. Researchers say the technology could one day be used in various medical applications such as blood-based tests for early cancer screening, monitoring disease biomarkers and real-time detection of viral and microbial sequences. The advance was published June 13 in the online early edition of Proceedings of the National Academy of Sciences ("Highly specific SNP detection using 2D graphene electronics and DNA strand displacement"). We are at the forefront of developing a fast and inexpensive digital method to detect gene mutations at high resolution—on the scale of a single nucleotide change in a nucleic acid sequence,” said Ratnesh Lal, professor of bioengineering, mechanical engineering and materials science in the Jacobs School of Engineering at UC San Diego. The technology, which is at a proof-of-concept stage, is a first step toward a b

Fuel is necessity of all but fuel source is less here is the bionic leaf which produce fuel. Photosynthesis has long been looked at as the gold standard for turning sunlight into energy and it only makes sense to look to plants for inspiration when building a new clean technology. Harvard and many other labs have been working on artificial leaves for years. Usually the result is a solar technology that when submerged in water or connected to a water source can split the water molecules into oxygen and hydrogen for use in a fuel cell. Last year, Harvard debuted their bionic leaf which goes beyond that and turns sunlight into liquid fuel. The system uses solar energy to split the water molecules, but also contains hydrogen-eating bacteria that produces liquid fuel. The bionic leaf has now gotten a significant upgrade and has far surpassed the ability of plants themselves to produce fuel from sunlight. “This is a true artificial photosynthesis system,” said Professor of Energy Daniel